chr12-6540568-G-A
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_001193457.2(IFFO1):c.1631C>T(p.Ala544Val) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000682 in 1,613,770 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_001193457.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
IFFO1 | NM_001193457.2 | c.1631C>T | p.Ala544Val | missense_variant | 10/10 | ENST00000619571.5 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
IFFO1 | ENST00000619571.5 | c.1631C>T | p.Ala544Val | missense_variant | 10/10 | 2 | NM_001193457.2 | A1 |
Frequencies
GnomAD3 genomes AF: 0.0000920 AC: 14AN: 152220Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.000129 AC: 32AN: 248636Hom.: 0 AF XY: 0.000111 AC XY: 15AN XY: 134820
GnomAD4 exome AF: 0.0000650 AC: 95AN: 1461432Hom.: 0 Cov.: 31 AF XY: 0.0000605 AC XY: 44AN XY: 727028
GnomAD4 genome AF: 0.0000985 AC: 15AN: 152338Hom.: 0 Cov.: 32 AF XY: 0.000107 AC XY: 8AN XY: 74498
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jun 30, 2022 | The c.1631C>T (p.A544V) alteration is located in exon 10 (coding exon 10) of the IFFO1 gene. This alteration results from a C to T substitution at nucleotide position 1631, causing the alanine (A) at amino acid position 544 to be replaced by a valine (V). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at